A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies.

Name: A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies.
License: Public Domain

Novartis Pharmaceuticals

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

non

non-small cell lung cancer (nsclc), triple negative breast cancer (tnbc), pancreatic ductal adenocarcinoma (pdac), colorectal cancer microsatellite stable (mss), ovarian cancer, renal cell carcinoma (rcc)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies.

Related documents